Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

Hypo-RESOLVE Consortium; Patrick Divilly; Gilberte Martine-Edith; Natalie Zaremba; Uffe Søholm; Zeinab Mahmoudi; Monika Cigler; Namam Ali; Evertine J. Abbink; Julie Brøsen; Bastiaan de Galan; Ulrik Pedersen-Bjergaard; Allan A. Vaag; Rory J. McCrimmon; Eric Renard; Simon Heller; Mark Evans; Julia K. Mader; Stephanie A. Amiel; Frans Pouwer; Pratik Choudhary

doi:10.2337/dc23-2332

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

Hypo-RESOLVE Consortium, Patrick Divilly (Lead / Corresponding author), Gilberte Martine-Edith, Natalie Zaremba, Uffe Søholm, Zeinab Mahmoudi, Monika Cigler, Namam Ali, Evertine J. Abbink, Julie Brøsen, Bastiaan de Galan, Ulrik Pedersen-Bjergaard, Allan A. Vaag, Rory J. McCrimmon, Eric Renard, Simon Heller, Mark Evans, Julia K. Mader, Stephanie A. Amiel, Frans PouwerPratik Choudhary

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

18 Downloads (Pure)

Abstract

OBJECTIVE

Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia.

RESEARCH DESIGN AND METHODS

We recruited 276 participants with T1D and 321 with T2D who wore a blinded CGM and recorded PRH in the Hypo-METRICS app over 10 weeks. Rates of SDH <70 mg/dL, SDH <54 mg/dL, and PRH were expressed as median episodes per week. Episodes of SDH were matched to episodes of PRH that occurred within 1 h.

RESULTS

Median [interquartile range] rates of hypoglycemia were significantly higher in T1D versus T2D; for SDH <70 mg/dL (6.5 [3.8-10.4] vs. 2.1 [0.8-4.0]), SDH <54 mg/dL (1.2 [0.4-2.5] vs. 0.2 [0.0-0.5]), and PRH (3.9 [2.4-5.9] vs. 1.1 [0.5-2.0]). Overall, 65% of SDH <70 mg/dL was not associated with PRH, and 43% of PRH had no associated SDH. The median proportion of SDH associated with PRH in T1D was higher for SDH <70 mg/dL (40% vs. 22%) and SDH <54 mg/dL (47% vs. 25%) than in T2D.

CONCLUSIONS

The novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.

Original language	English
Pages (from-to)	1769-1777
Number of pages	9
Journal	Diabetes Care
Volume	47
Issue number	10
DOIs	https://doi.org/10.2337/dc23-2332
Publication status	Published - Oct 2024

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialised Nursing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc23-2332

Author Accepted ManuscriptAccepted author manuscript, 601 KBLicence: CC BY

Cite this

Hypo-RESOLVE Consortium, Divilly, P., Martine-Edith, G., Zaremba, N., Søholm, U., Mahmoudi, Z., Cigler, M., Ali, N., Abbink, E. J., Brøsen, J., de Galan, B., Pedersen-Bjergaard, U., Vaag, A. A., McCrimmon, R. J., Renard, E., Heller, S., Evans, M., Mader, J. K., Amiel, S. A., ... Choudhary, P. (2024). Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study. Diabetes Care, 47(10), 1769-1777. https://doi.org/10.2337/dc23-2332

@article{1a9ed848f23f4a3d93f47fe4d6ae66cd,

title = "Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study",

abstract = "OBJECTIVE Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia. RESEARCH DESIGN AND METHODS We recruited 276 participants with T1D and 321 with T2D who wore a blinded CGM and recorded PRH in the Hypo-METRICS app over 10 weeks. Rates of SDH <70 mg/dL, SDH <54 mg/dL, and PRH were expressed as median episodes per week. Episodes of SDH were matched to episodes of PRH that occurred within 1 h. RESULTS Median [interquartile range] rates of hypoglycemia were significantly higher in T1D versus T2D; for SDH <70 mg/dL (6.5 [3.8-10.4] vs. 2.1 [0.8-4.0]), SDH <54 mg/dL (1.2 [0.4-2.5] vs. 0.2 [0.0-0.5]), and PRH (3.9 [2.4-5.9] vs. 1.1 [0.5-2.0]). Overall, 65% of SDH <70 mg/dL was not associated with PRH, and 43% of PRH had no associated SDH. The median proportion of SDH associated with PRH in T1D was higher for SDH <70 mg/dL (40% vs. 22%) and SDH <54 mg/dL (47% vs. 25%) than in T2D. CONCLUSIONSThe novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.",

author = "{Hypo-RESOLVE Consortium} and Patrick Divilly and Gilberte Martine-Edith and Natalie Zaremba and Uffe S{\o}holm and Zeinab Mahmoudi and Monika Cigler and Namam Ali and Abbink, {Evertine J.} and Julie Br{\o}sen and {de Galan}, Bastiaan and Ulrik Pedersen-Bjergaard and Vaag, {Allan A.} and McCrimmon, {Rory J.} and Eric Renard and Simon Heller and Mark Evans and Mader, {Julia K.} and Amiel, {Stephanie A.} and Frans Pouwer and Pratik Choudhary",

note = "Publisher Copyright: {\textcopyright} 2024 by the American Diabetes Association.",

year = "2024",

month = oct,

doi = "10.2337/dc23-2332",

language = "English",

volume = "47",

pages = "1769--1777",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "10",

}

Hypo-RESOLVE Consortium, Divilly, P, Martine-Edith, G, Zaremba, N, Søholm, U, Mahmoudi, Z, Cigler, M, Ali, N, Abbink, EJ, Brøsen, J, de Galan, B, Pedersen-Bjergaard, U, Vaag, AA, McCrimmon, RJ, Renard, E, Heller, S, Evans, M, Mader, JK, Amiel, SA, Pouwer, F & Choudhary, P 2024, 'Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study', Diabetes Care, vol. 47, no. 10, pp. 1769-1777. https://doi.org/10.2337/dc23-2332

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study. / Hypo-RESOLVE Consortium; Divilly, Patrick (Lead / Corresponding author); Martine-Edith, Gilberte et al.
In: Diabetes Care, Vol. 47, No. 10, 10.2024, p. 1769-1777.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes

T2 - The Hypo-METRICS Study

AU - Hypo-RESOLVE Consortium

AU - Divilly, Patrick

AU - Martine-Edith, Gilberte

AU - Zaremba, Natalie

AU - Søholm, Uffe

AU - Mahmoudi, Zeinab

AU - Cigler, Monika

AU - Ali, Namam

AU - Abbink, Evertine J.

AU - Brøsen, Julie

AU - de Galan, Bastiaan

AU - Pedersen-Bjergaard, Ulrik

AU - Vaag, Allan A.

AU - McCrimmon, Rory J.

AU - Renard, Eric

AU - Heller, Simon

AU - Evans, Mark

AU - Mader, Julia K.

AU - Amiel, Stephanie A.

AU - Pouwer, Frans

AU - Choudhary, Pratik

PY - 2024/10

Y1 - 2024/10

N2 - OBJECTIVE Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia. RESEARCH DESIGN AND METHODS We recruited 276 participants with T1D and 321 with T2D who wore a blinded CGM and recorded PRH in the Hypo-METRICS app over 10 weeks. Rates of SDH <70 mg/dL, SDH <54 mg/dL, and PRH were expressed as median episodes per week. Episodes of SDH were matched to episodes of PRH that occurred within 1 h. RESULTS Median [interquartile range] rates of hypoglycemia were significantly higher in T1D versus T2D; for SDH <70 mg/dL (6.5 [3.8-10.4] vs. 2.1 [0.8-4.0]), SDH <54 mg/dL (1.2 [0.4-2.5] vs. 0.2 [0.0-0.5]), and PRH (3.9 [2.4-5.9] vs. 1.1 [0.5-2.0]). Overall, 65% of SDH <70 mg/dL was not associated with PRH, and 43% of PRH had no associated SDH. The median proportion of SDH associated with PRH in T1D was higher for SDH <70 mg/dL (40% vs. 22%) and SDH <54 mg/dL (47% vs. 25%) than in T2D. CONCLUSIONSThe novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.

AB - OBJECTIVE Use of continuous glucose monitoring (CGM) has led to greater detection of hypoglycemia; the clinical significance of this is not fully understood. The Hypoglycaemia-Measurement, Thresholds and Impacts (Hypo-METRICS) study was designed to investigate the rates and duration of sensor-detected hypoglycemia (SDH) and their relationship with person-reported hypoglycemia (PRH) in people living with type 1 diabetes (T1D) and insulin-treated type 2 diabetes (T2D) with prior experience of hypoglycemia. RESEARCH DESIGN AND METHODS We recruited 276 participants with T1D and 321 with T2D who wore a blinded CGM and recorded PRH in the Hypo-METRICS app over 10 weeks. Rates of SDH <70 mg/dL, SDH <54 mg/dL, and PRH were expressed as median episodes per week. Episodes of SDH were matched to episodes of PRH that occurred within 1 h. RESULTS Median [interquartile range] rates of hypoglycemia were significantly higher in T1D versus T2D; for SDH <70 mg/dL (6.5 [3.8-10.4] vs. 2.1 [0.8-4.0]), SDH <54 mg/dL (1.2 [0.4-2.5] vs. 0.2 [0.0-0.5]), and PRH (3.9 [2.4-5.9] vs. 1.1 [0.5-2.0]). Overall, 65% of SDH <70 mg/dL was not associated with PRH, and 43% of PRH had no associated SDH. The median proportion of SDH associated with PRH in T1D was higher for SDH <70 mg/dL (40% vs. 22%) and SDH <54 mg/dL (47% vs. 25%) than in T2D. CONCLUSIONSThe novel findings are that at least half of CGM hypoglycemia is asymptomatic, even below 54 mg/dL, and many reported symptomatic hypoglycemia episodes happen above 70 mg/dL. In the clinical and research setting, these episodes cannot be used interchangeably, and both need to be recorded and addressed.

U2 - 10.2337/dc23-2332

DO - 10.2337/dc23-2332

M3 - Article

C2 - 39207738

AN - SCOPUS:85204660830

SN - 0149-5992

VL - 47

SP - 1769

EP - 1777

JO - Diabetes Care

JF - Diabetes Care

IS - 10

ER -

Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this